This is an Open Access article licensed under the terms of the Creative Commons AttributionNonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only. Methods: Differentiated podocytes were divided into: the normal glucose group (NG: glucose 5.6mM), the HG groups (12.5HG: 12.5mM; 25HG: 25mM; and 50HG: 50mM of glucose), and the osmotic control group (NG+M: glucose 5.6mM and mannitol 44.4mM). GSK-3β, β-catenin and Snail were assessed using semi-quantitative RT-PCR, western blot and immunofluorescence. β-catenin and Snail pathways were assessed after down-regulating GSK-3β expression using an inhibitor (LiCl) or a small-interfering RNA (siRNA). Results: HG increased GSK-3β, β-catenin and Snail expressions, and promoted EMT, as shown by decreased nephrin expression (epithelial marker), and increased α-SMA expression (mesenchymal marker). GSK-3β inhibitor and GSK-3β siRNA decreased β-catenin and Snail expressions, and reversed HG-induced EMT. Immunofluorescence showed that GSK-3β and β-catenin did not completely overlap; β-catenin was transferred to the nucleus in the 25HG group. VDR seems to be involved in HG-induced β-catenin nuclear translocation. Conclusion: Down-regulating GSK-3β expression decreased β-catenin and Snail expression and reversed HG-induced podocytes EMT. Thus, modulating GSK-3β might be a target to slow or prevent DN.
Introduction
Diabetic nephropathy (DN) is one of the most common microvascular complications in diabetes, and has become the leading cause of end-stage renal diseases (ESRD) [1] . DN is characterized by structural and functional changes in the kidney. The major clinical manifestations are proteinuria, hematuria and progressive chronic kidney diseases [2] . These complications may be slowed or prevented using the appropriate therapy [2] . Nevertheless, ESRD still affect 15 cases per 1000 patient-years [3] .
Podocytes are located in the glomerular basement membrane, and are highly differentiated epithelial cells, forming the outermost layers of the glomerular filtration barrier. Recent studies showed that podocyte injury plays an important role in DN and in proteinuria [4] , and accumulating evidences suggest that DN is more a "podocyte disease" [5] . Epithelial-mesenchymal transition (EMT) is a pathological phenomenon by which normal epithelial cells lose their characteristics, such as cell polarity and adhesion, and gain characteristics of mesenchymal cells, such as migration and invasion [6] . EMT is essential to normal embryogenesis and wound healing, but is also involved in organ fibrosis, metastases and DN [7] . Some studies support the concept that high glucose (HG) environment, such as the one observed in diabetes, could be involved in podocytes EMT [8] [9] [10] . Indeed, podocytes' proteins, such as nephrin and zonula occludens-1, are lost in the HG environment, while mesenchymal cell proteins such as α-SMA and fibronectin are expressed, leading to podocytes' dysfunction and proteinuria [11] [12] [13] [14] .
Glycogen synthase kinase 3β (GSK-3β) is a serine/threonine phosphate kinase involved in glucose synthesis, and plays an important role in variety of cell activities and functions, such as proliferation, migration, inflammation, immune response, glucose regulation and apoptosis [15] . Wnt/β-catenin is now recognized as one of the cell signaling pathways involved in EMT [16] . In addition, the Snail pathway affects EMT by modulating the expression of the downstream β-catenin [17] . GSK-3β plays an important role in the β-catenin pathway [18] . Vitamin D receptor (VDR) is involved in organ fibrosis through changes in β-catenin expression and intracellular localization [19] .
GSK-3β is a key regulator of numerous signaling pathways [20] , but the exact relationship between GSK-3β, β-catenin, Snail and VDR in podocytes' EMT under HG conditions is also still unclear. Thus, the present study was to analyze the role of GSK-3β, β-catenin, Snail and VDR in HG-induced podocytes' EMT. Results from the present study could provide new knowledge on DN pathogenesis and new ways to prevent or treat it.
Materials and Methods

Cell culture
Conditional immortalized mouse podocytes were provided by Professor Nie Jing (Southern Medical University, Guangzhou, China). Podocytes were cultured according to the method by Mundel et al. [21] . Undifferentiated podocytes were cultured in RPMI1640 medium (GIBCO, USA) with 10% fetal bovine serum (FBS) (GIBCO), 5.6mmol/L of glucose (Dingguo Changsheng Biotech Co., Ltd., Beijing, China), and 10U/ml of recombinant mice interferon-γ (Sangon Biotech, Shanghai, China), in an incubator at 33°C in 5% CO 2 . After differentiation, podocytes were cultures at 37°C in RPMI1640 medium without recombinant mice interferon-γ. Podocytes were cultured for 12-14 days before being ready for the next experiments.
Five groups of podocytes were created: the normal glucose group (NG: 5.6mM of glucose), the high glucose groups (12.5HG: 12.5mM; 25HG: 25mM; and 50HG: 50mM of glucose), and the osmotic control group (NG+M: 5.6mM of glucose and 44.4mM of mannitol (Dingguo Changsheng Biotech Co., Ltd.), which had an osmotic pressure comparable with the 25HG group). Experiments also used water-soluble LiCl (Dingguo Changsheng Biotech Co., Ltd.), a GSK-3β inhibitor, a final concentration of 10mM of LiCl. Finally, a small interference RNA (siRNA) against GSK-3β (Genechem, Shanghai, China) was also used in this study. 
siRNA transfection
The sequence of the siRNA against GSK-3β was 5'-CCA CTC AAG AAC TGT CAA GTA-3'), based on the GSK-3β full-length mouse gene (GeneBank NO. NM 019827.6). The sequence of the scramble siRNA was 5'-UUC UCC GAA CGU GUC ACG UTT-3'. GSK-3β and scramble siRNA were transfected into differentiated podocytes using Lipofectamine 2000 (Invitrogen Inc., Carlsbad, CA, USA).
Semi-quantitative RT-PCR
Total RNA was extracted from each group using Trizol (Invitrogen Inc., Carlsbad, CA, USA), according to the manufacturer's instructions. RNA purity was determined using absorbance at 260 and 280 nm (A260/280). RNA integrity was verified by formaldehyde-denaturing gel electrophoresis. cDNA was synthesized using 2μg of RNA and the First Strand cDNA Synthesis Kit (Fermentas, Burlington, Canada) using the M-MuLV Reverse Transcriptase and random primers. The sequences of specific primers were shown in Table 1 . cDNA (1μl) was mixed with the forward and reverse primers (each 0.5μl), 2×PCR Master Mix (12.5μl) (Life Technologies Co., Grand Island, NY, USA) and deionized water (for total volume of 25μl), and reaction was performed in a thermocycler (BD Diagnostics, Sparks, MD, USA). PCR products were separated on 2.0% agarose gel electrophoresis. The Image J image software (National Institutes of Health, USA) was used to quantify the grayscale value.
Western blot
Total proteins were obtained from each group using the RIPA lysis buffer (Dingguo Changsheng Biotech Co., Ltd.). Proteins were quantified using a BCA protein assay kit (Dingguo Changsheng Biotech Co., Ltd.). Proteins (15-20µg) were separated using 10% SDS-PAGE, and were transferred on PVDF membranes (Roche, Mannheim, Germany). Non-specific sites were blocked using 5% powdered milk diluted in TBS with 0.05% Tween 20 (TBST) for 1h. Primary antibody was incubated overnight at 4°C. After washing the membranes, the secondary antibody was incubated at 37°C for 2h. An ECL chemiluminescence reagent kit (CoWin Biotech, Beijing, China) was used to reveal the bands. Blots were analyzed using the ImageJ software. Antibodies were: mouse polyclonal antibody against GAPDH (Shanghai Kang Cheng biological engineering Co., Ltd., China), mouse polyclonal antibody against β-catenin, antibody against Snail (Abcam, Cambridge, MA, USA), mouse polyclonal antibody against VDR (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and horseradish peroxidase-labeled goat anti-mouse secondary antibody (Dingguo Changsheng Biotech Co., Ltd.).
Immunofluorescence
Podocytes were stimulated by 25mM of glucose for 36h, and were fixed in 4°C 4% paraformaldehyde for 20 min, 0.6% Tween-20 for 15min, and blocked with 5% BSA blocking solution for 20 min at room temperature. Cells were exposed overnight to antibodies against β-catenin, GSK-3β (Abcam, Cambridge, MA, USA) and VDR (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Cells were washed three times in PBS. Cells were revealed using the Alexa Fluor 488 goat anti-rabbit IgG (H+L) (green) and the Alexa Fluor 594 donkey anti-mouse IgG (H+L) (red) (Invitrogen Inc., Carlsbad, CA, USA) at 37°C for 1 h. Fluorescence was observed using a fluorescence microscope (Olympus, CX31-32RFL, Japan). 
Statistical analysis
All data were obtained from three independent experiments, and are expressed as mean ± standard error of the mean (SEM). SPSS17.0 (SPSS Inc., Chicago, IL, USA) was used for statistical analysis. Statistical significance was evaluated by one-way analysis of variance (ANOVA) with Student-Newman-Keuls (SNK) test for post hoc analysis. P-values <0.05 were considered statistically significant.
Results
HG stimulation up-regulated GSK-3β, β-catenin and Snail expression and promoted EMT in the differentiated podocytes
Using differentiated podocytes cultured in the normal glucose group (NG: 5.6mM of glucose), the high glucose groups (12.5HG: 12.5mM; 25HG: 25mM; and 50HG: 50mM of glucose), and the osmotic control group (NG+M: 5.6mM of glucose and 44.4mM of mannitol) for 36 hours, RT-PCR and Western blot experiments showed that with increasing glucose levels, the expressions of GSK-3β, β-catenin and Snail mRNA and protein increased (all P<0.05), and there was no significant difference between NG and NG+M group (Fig. 1A-1F) .
To confirm HG promoting podocytes' EMT, the expressions of the epithelial marker, nephrin, and of the mesenchymal marker, α-SMA, were determined by RT-PCR. Compared 
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and also decreased GSK-3β protein expressions (Fig. 2B ). NG and 25HG podocytes were transfected with GSK-3β siRNA or scramble siRNA for 36h. β-catenin and Snail mRNA and protein expression levels were detected. As shown in Figures 3A and 3B 
GSK-3β inhibitor LiCl decreases β-catenin and Snail expressions and reverses HG-induced EMT in the differentiated podocytes
Podocytes from the NG and 25HG groups were treated with GSK-3β inhibitor LiCl (10mM) for 36h, and β-catenin and Snail mRNA and protein expression levels were detected. As shown in Figures 4A and 4B , β-catenin and Snail mRNA and protein were increased in the 25HG group (all P<0.05). After treatment with LiCl, expression of β-catenin and Snail mRNA and protein in the 25HG group were decreased compared with the untreated group, but remained higher than in the NG group (all P<0.05). 
HG stimulation down-regulated VDR expression in the differentiated podocytes
Using differentiated podocytes cultured in different glucose concentration for 36 hours, RT-PCR and western blot experiments showed that VDR expression was decreased with increasing concentrations of glucose (all P<0.05), and there was no significant difference between NG and NG+M group (Fig. 6A and 6B) .
Podocytes from the NG and 25HG groups were treated with fluorescence-labeled antibodies against VDR and β-catenin. As shown in Figure 6C , VDR and β-catenin overlapped in the 25HG and NG groups, and β-catenin was transferred to the nucleus in the 25HG group. 5 . GSK-3β and β-catenin immunofluorescence in NG and 25HG podocytes (×400).HG environment increased the expression of GSK-3β and β-catenin compared with the NG group. In the HG group, β-catenin was localized in the nucleus. In the HG group, GSK-3β and β-catenin did not completely overlap. Green: Alexa Fluor 488; Red: Alexa Fluor 594. 
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Experiments showed that the podocytes' EMT process in HG environment may also involve VDR regulating β-catenin's intracellular localization.
Discussion
GSK-3β is necessary to maintain epithelial cells' structure [22] . TGFβ/Smad, ILK and Wnt/β-catenin are recognized to participate in the signaling pathways leading to cell transdifferentiation [7, 23, 24] , GSK-3β plays an important role in these three pathways by providing a connecting link between them. Thus, changes in GSK-3β activity will affect the expression of differentiation factors, thus affecting the EMT process. Studies have found that GSK-3β participate in renal EMT [25] . In the present study, down-regulating GSK-3β expression decreased β-catenin and Snail expression and reversed HG-induced EMT of podocytes.
Wnt signaling pathway is mainly involved in the regulation of cell differentiation, especially in malignant tumor cells, affecting the invasion and mobility of tumor cell [26] . β-catenin is a multifunctional protein, and is a key factor involved in classic Wnt signaling [27] . Under normal circumstances, free β-catenin is phosphorylated and degraded by the proteasome. When Wnt signaling is activated, most β-catenin is unphosphorylated, leading to β-catenin accumulation in the cytoplasm, entry into the nucleus in combination with T cells nuclear factor/lymphatic enhancement factors (TCF/LEF), and modulation of the expression of target genes involved in a variety of physiological mechanisms [23] . Snail gene is activated by the Wnt/β-catenin pathway [28] . High expression of Snail can decrease the expression of E-cadherin, reducing the adhesion between epithelial cells, and participating in EMT [29] . On the other hand, high expression of Snail interact with β-catenin, further activating Wnt signaling and activating target genes [28] , leading to EMT. Studies showed that GSK-3β can modulate Snail activity [24, 30] .
GSK-3β participates in podocytes' EMT in the HG environment [24] . However, whether GSK-3β regulates Wnt/β-catenin signaling and its effects on podocytes' EMT under HG were still unclear. The present study showed that with increasing glucose levels, GSK-3β expression increased, affecting the expression of β-catenin and Snail. When down-regulation of GSK-3β expression, the expression of β-catenin and Snail decreased. According to our results, we speculated that GSK-3β may regulate the expression of β-catenin and Snail to influence podocytes' EMT in the HG environment.
It was usually believed that GSK-3β could phosphorylate β-catenin, resulting in proteasome degradation [23, 27] . However, in recent years, studies on GSK-3β and Wnt/ β-catenin signaling in tumor cells suggested that inhibition of GSK-3β could both inhibit or promote Wnt/β-catenin signaling [31] . GSK-3β has two ways to modulate β-catenin, revealing that GSK-3β can negatively regulate Wnt/β-catenin signaling through degradation of β-catenin (the traditional view), but can also positively control expression of β-catenin by an even more complex regulatory mechanism [32, 33] . Thus, we speculated that HGinduced EMT is not entirely mediated by the classical GSK-3β pathway, but that other factors are involved. Thus, using an indirect immunofluorescence method, we observed that the localization of GSK-3β and β-catenin in the cell nucleus did not fully overlap in the HG group compared with the NG group, confirming our inference that β-catenin expression is not entirely modulated by GSK-3β through the classical Wnt/β-catenin pathway.
Therefore, we hypothesized that the influence of the HG environment on β-catenin in podocytes may not only be through GSK-3β, but also from other pathways influencing β-catenin's expression and intracellular localization. Studies in breast and colon cancer cells found that VDR, β-catenin and Snail are interrelated [34] . Studies showed that vitamin D and VDR may help to alleviate EMT, and that nucleus β-catenin could be reduced [35, 36] . When VDR is activated, it will compete with β-catenin for combination with TCF-4, thus inhibiting the activity of β-catenin in colon cancer [36] . In a mouse model of unilateral ureteral obstruction, VDR was related to the degree of renal fibrosis, and was involved in
